John Peter Gutfreund - Dec 23, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Gutfreund John Peter
Stock symbol
OCX
Transactions as of
Dec 23, 2022
Transactions value $
$24,728
Form type
4
Date filed
12/28/2022, 03:05 PM
Previous filing
Aug 17, 2022
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $24.7K +75K $0.33 75K Dec 23, 2022 see footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $0.3297 per share represents a weighted average of prices ranging from $0.31 to $0.33 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The shares of common stock are held by Newtown Road 130 Holdings LLC. The Reporting Person is the Managing Member of Newtown Road 130 Holdings LLC and in such capacity has the right to vote and dispose of the securities held by such entity.